No price history available.
Key financial summary
Financials in CHF| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CHFm | 824 | 662 | 646 | 495 | 283 | 195 | N/A | N/A |
| Operating profit | CHFm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | CHFm | 14 | 49 | 130 | 22 | 53 | -15 | N/A | N/A |
| EPS reported | CHF | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | CHF | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | CHF | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | CHF | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | CHFm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | CHFm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | CHFm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | CHF | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | CHF | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in CHF| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Metall Zug AG, established in 1887 and based in Zug, Switzerland, operates globally through its subsidiaries across diverse sectors including wire processing, medical devices, infection control, technology cluster and infrastructure, and other specialized businesses. Its operations extend across Switzerland, Europe, the Americas, Asia Pacific, and other international markets. The company's Wire Processing division specializes in the design, manufacture, and supply of advanced automated and semi-automated machinery for a wide array of wire and cable handling tasks, such as cutting, stripping, crimping, sealing, twisting, tinning, printing, quality control, and process and test automation. This segment also provides accompanying software solutions designed to optimize operational efficiency, machine utilization for intricate tasks, and data connectivity. The Medical Devices business unit focuses on the creation, production, and distribution of diagnostic and microsurgical instruments. While primarily serving the ophthalmology sector, it also addresses applications in pulmonology and general measurement instrumentation. Diagnostic offerings include tools like slit lamps, biometers, perimeters, tonometers, and practice management software for clinics and opticians, alongside essential practice equipment. Surgical products encompass microscopes, various stands (floor and roof-mounted), and complementary accessories. Within Infection Control, Metall Zug delivers cleaning, disinfection, and sterilization technologies predominantly utilized in healthcare settings, particularly hospitals. The Technologycluster & Infrastructure unit is dedicated to the management and development of its real estate portfolio. Finally, the company's Others business unit provides specialized cleaning, disinfection, and sterilization systems and solutions primarily for the pharmaceutical industry. It also supplies professional-grade appliances and integrated solutions, such as dishwashers, cooking equipment, cleaning agents, and comprehensive care systems, catering to the hotel and catering sector, care facilities, and hospitals.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Metall Zug AG, established in 1887 and based in Zug, Switzerland, operates globally through its subsidiaries across diverse sectors including wire processing, medical devices, infection control, technology cluster and infrastructure, and other specialized businesses. Its operations extend across Switzerland, Europe, the Americas, Asia Pacific, and other international markets. The company's Wire Processing division specializes in the design, manufacture, and supply of advanced automated and semi-automated machinery for a wide array of wire and cable handling tasks, such as cutting, stripping, crimping, sealing, twisting, tinning, printing, quality control, and process and test automation. This segment also provides accompanying software solutions designed to optimize operational efficiency, machine utilization for intricate tasks, and data connectivity. The Medical Devices business unit focuses on the creation, production, and distribution of diagnostic and microsurgical instruments. While primarily serving the ophthalmology sector, it also addresses applications in pulmonology and general measurement instrumentation. Diagnostic offerings include tools like slit lamps, biometers, perimeters, tonometers, and practice management software for clinics and opticians, alongside essential practice equipment. Surgical products encompass microscopes, various stands (floor and roof-mounted), and complementary accessories. Within Infection Control, Metall Zug delivers cleaning, disinfection, and sterilization technologies predominantly utilized in healthcare settings, particularly hospitals. The Technologycluster & Infrastructure unit is dedicated to the management and development of its real estate portfolio. Finally, the company's Others business unit provides specialized cleaning, disinfection, and sterilization systems and solutions primarily for the pharmaceutical industry. It also supplies professional-grade appliances and integrated solutions, such as dishwashers, cooking equipment, cleaning agents, and comprehensive care systems, catering to the hotel and catering sector, care facilities, and hospitals.
